Latin America Pharmaceutical Industry Analysis
The Latin American pharmaceutical market was valued at $60 billion in 2019, with Brazil accounting for nearly half of regional sales. The industry continues to grow with strong generic drug production and increasing biotechnology investments.
The pharmaceutical industry in Latin America is dynamic and consistently developing. Three countries with the strongest presence in the region include Brazil, Argentina, and Mexico. These nations have seen rapid growth in major pharmaceutical players. While the region lags in patent registrations compared to developed markets, it has a robust market for generic drugs, OTC medications, pharmaceutical ingredients, veterinary drugs, and biotechnology ventures.
One notable example is Teva Pharmaceutical Industries' acquisition of Ivax Corporation for $7.4 billion, which included operations across nine Latin American countries. Teva further strengthened its position by acquiring Representaciones e Investigaciones Médicas S.A. in Mexico for $2.3 billion. Today, Teva dominates the generic drug market in Latin America and globally, with annual sales approaching $20 billion.
Brazil: The Regional Leader
Brazil boasts the most significant pharmaceutical industry in Latin America. Key players include:
- Hypera Pharma S.A. (OTC and pharmaceutical ingredients)
- EMS S.A. (generics and branded drugs)
- Aché Laboratórios (biotechnology and distribution)
- Eurofarma (regional operations across Latin America)
Aché Laboratórios has particularly diversified interests, including a joint venture with Canadian Scythian Biosciences for therapeutic cannabis through Green Farma Brasil.
Argentina: Strong Local Players
Argentina's pharmaceutical sector features prominent companies like:
- Laboratorios Roemmers (vertically integrated with vaccine development)
- Insud Pharma (pharmaceutical ingredients and biotechnology)
- Laboratorios Bagó (human and veterinary medicines)
Insud Pharma maintains an especially diverse portfolio through subsidiaries like mAbxience (biotech) and Biogénesis Bagó (veterinary vaccines).
Mexico: Growing Market
Mexico's pharmaceutical industry is expanding with major participants including:
- Laboratorios Pisa S.A. (research-based medicines)
- Genomma Lab Internacional (OTC and generics)
- Teva Mexico (generic pharmaceuticals)
Distribution is dominated by Grupo Casa Saba, one of Latin America's largest pharmaceutical distributors.
Other Key Markets
Venezuela
Despite challenges, Venezuela maintains pharmaceutical operations through companies like Laboratorio Behrens and SM Pharma, though many have relocated operations abroad.
Colombia
Colombia's market features established players like Laboratorios Lafrancol and Laboratorios Junín.
Peru
Peru's industry includes Teva subsidiaries Corporación Medco and Corporación Infarmasa, along with local producer Laboratorios Lansier.
El Salvador
This growing market includes Laboratorios López and Laboratorios Suizos, with distribution handled by Droguería Sinquimia.
No comments:
Post a Comment